Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer. (Q53067336)

11 May 2018

title

Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer. (English)

1 reference

11 May 2018

author name string

Yukie Yoda

1

1 reference

11 May 2018

Hideyuki Takeshima

2

1 reference

11 May 2018

Tohru Niwa

3

1 reference

11 May 2018

Jeong Goo Kim

4

1 reference

11 May 2018

Takayuki Ando

5

1 reference

11 May 2018

Ryoji Kushima

6

1 reference

11 May 2018

Toshiro Sugiyama

7

1 reference

11 May 2018

Hitoshi Katai

8

1 reference

11 May 2018

Hirokazu Noshiro

9

1 reference

11 May 2018

Toshikazu Ushijima

10

1 reference

11 May 2018

publication date

9 February 2014

1 reference

11 May 2018

published in

Gastric Cancer

1 reference

11 May 2018

volume

18

1 reference

11 May 2018

issue

1

1 reference

11 May 2018

page(s)

65-76

1 reference

11 May 2018

https://scigraph.springernature.com/pub.10.1007/s10120-014-0348-0

exact match

0 references

cites work

High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Gene methylation in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

E-cadherin germline mutations in familial gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Targeting the epigenome for treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

BET bromodomain inhibition as a therapeutic strategy to target c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Clinical integration of next-generation sequencing technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Comprehensive DNA methylation and extensive mutation analyses reveal an association between the CpG island methylator phenotype and oncogenic mutations in gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

The epigenomics of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Helicobacter pylori infection and the risk of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Trials with 'epigenetic' drugs: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Development of a novel output value for quantitative assessment in methylated DNA immunoprecipitation-CpG island microarray analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Development of a novel approach, the epigenome-based outlier approach, to identify tumor-suppressor genes silenced by aberrant DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

IGFBP7 plays a potential tumor suppressor role in colorectal carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0348-0

Detection and interpretation of altered methylation patterns in cancer cells

21 January 2018

1 reference

12 December 2020

DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis

1 reference

12 December 2020

Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability

1 reference

12 December 2020

Identification of a DNA methylation marker that detects the presence of lymph node metastases of gastric cancers

1 reference

12 December 2020

Evaluation of the Infinium Methylation 450K technology

1 reference

12 December 2020

DNA methylation of multiple genes in gastric carcinoma: Association with histological type and CpG island methylator phenotype

1 reference

12 December 2020

Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.

1 reference

12 December 2020

Methylation of p16 CpG islands associated with malignant transformation of gastric dysplasia in a population-based study

1 reference

12 December 2020

10.1007/S10120-014-0348-0

Identifiers

DOI

1 reference

11 May 2018

release_35bs3h34rbaytlp6ifydlysmwe

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/35bs3h34rbaytlp6ifydlysmwe

24 November 2022

mapped directly with Wikidata item

PubMed ID

24510342

1 reference

11 May 2018